Influenzinum 2015-2016 (Energique, Inc.)


Welcome to the PulseAid listing for the Influenzinum 2015-2016 drug offered from Energique, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Energique, Inc.
NON-PROPRIETARY NAME: Influenzinum
SUBSTANCE NAME: INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED,
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-12-16
END MARKETING DATE: 2021-01-26


Influenzinum 2015-2016 HUMAN OTC DRUG Details:

Item DescriptionInfluenzinum 2015-2016 from Energique, Inc.
LABELER NAME: Energique, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 200; 200; 200; 200; 200; 200([hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL)
START MARKETING DATE: 2015-12-16
END MARKETING DATE: 2021-01-26
PRODUCT ID: 44911-0313_6f92f885-3688-4c32-bb74-c6f635653c68
PRODUCT NDC: 44911-0313
APPLICATION NUMBER:

Other INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Deseret Biologicals, Inc.Virus Plus
Energique, Inc.Influenzinum 2015-2016